NCT00442754View on ClinicalTrials.gov

Dendritic Cells in Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Non Small Cell Lung Cancer
Interventions
BIOLOGICAL

Allogeneic Tumour Lysate (MelCancerVac)

subcutaneaus, /once weekly /4 wks then /4 weekly

Trial Locations (1)

DK-2730 Herlev

Herlev University Hospital, Copenhagen

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Herlev Hospital

OTHER

NCT00442754 - Dendritic Cells in Lung Cancer | Biotech Hunter | Biotech Hunter